Skip to main content
PMC home page
Gut logoLink to Gut
. 1974 Jul;15(7):581–597. doi: 10.1136/gut.15.7.581

Chronic hepatitis.

S Sherlock
PMCID: PMC1412970  PMID: 4609843

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASHERSON G. L. Antibodies against nuclear and cytoplasmic cell constituents in systemic lupus erythematosus and other diseases. Br J Exp Pathol. 1959 Jun;40(3):209–215. [PMC free article] [PubMed] [Google Scholar]
  2. ASHERSON G. L. Antibodies against nuclear and cytoplasmic cell constituents in systemic lupus erythematosus and other diseases. Br J Exp Pathol. 1959 Jun;40(3):209–215. [PMC free article] [PubMed] [Google Scholar]
  3. Almeida J. D., Waterson A. P. Immune complexes in hepatitis. Lancet. 1969 Nov 8;2(7628):983–986. doi: 10.1016/s0140-6736(69)90540-6. [DOI] [PubMed] [Google Scholar]
  4. BEARN A. G., KUNKEL H. G., SLATER R. J. The problem of chronic liver disease in young women. Am J Med. 1956 Jul;21(1):3–15. doi: 10.1016/0002-9343(56)90003-1. [DOI] [PubMed] [Google Scholar]
  5. BOUCHIER I. A., RHODES K., SHERLOCK S. SEROLOGICAL ABNORMALITIES IN PATIENTS WITH LIVER DISEASE. Br Med J. 1964 Mar 7;1(5383):592–594. doi: 10.1136/bmj.1.5383.592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Becker M. D., Baptista A., Scheuer P. J., Sherlock S. Prognosis of chronic persistent hepatitis. Lancet. 1970 Jan 10;1(7637):53–57. doi: 10.1016/s0140-6736(70)91843-x. [DOI] [PubMed] [Google Scholar]
  7. Berg N. O., Eriksson S. Liver disease in adults with alpha-1 -antitrypsin deficiency. N Engl J Med. 1972 Dec 21;287(25):1264–1267. doi: 10.1056/NEJM197212212872502. [DOI] [PubMed] [Google Scholar]
  8. Berthelot P., Walker J. G., Sherlock S., Reid L. Arterial changes in the lungs in cirrhosis of the liver--lung spider nevi. N Engl J Med. 1966 Feb 10;274(6):291–298. doi: 10.1056/NEJM196602102740601. [DOI] [PubMed] [Google Scholar]
  9. Boxer L. A., Yokoyama M., Wiebe R. A. Autoimmune neutropenia associated with chronic active hepatitis. Am J Med. 1972 Feb;52(2):279–282. doi: 10.1016/0002-9343(72)90076-9. [DOI] [PubMed] [Google Scholar]
  10. Bridi G. S., Falcon P. W., Brackett N. C., Jr, Still W. J., Sporn I. N. Glomerulonephritis and renal tubular acidosis in a case of chronic active hepatitis with hyperimmunoglobulinemia. Am J Med. 1972 Feb;52(2):267–278. doi: 10.1016/0002-9343(72)90075-7. [DOI] [PubMed] [Google Scholar]
  11. Bulkley B. H., Goldfinger S. E., Heizer W. D., Isselbacher K. J., Shulman N. R. Distinctions in chronic active hepatitis based on circulating hepatitis-associated antigen. Lancet. 1970 Dec 26;2(7687):1323–1326. doi: 10.1016/s0140-6736(70)92356-1. [DOI] [PubMed] [Google Scholar]
  12. CATTAN R., VESIN P., BODIN H. Cirrhoses dysprotéinémiques d'origine inconnue chez la femme. Bull Mem Soc Med Hop Paris. 1957 Jun 14;73(20-21):608–616. [PubMed] [Google Scholar]
  13. CAVELL B., LEONHARDT T. HEREDITARY HYPERGAMMAGLOBULINEMIA AND LUPOID HEPATITIS. Acta Med Scand. 1965 Jun;177:751–759. doi: 10.1111/j.0954-6820.1965.tb01885.x. [DOI] [PubMed] [Google Scholar]
  14. CHRISPIN A. R., LESSOF L. THE CHEST RADIOGRAPH IN "JUVENILE" CIRRHOSIS (ACTIVE CHRONIC HEPATITIS). Br J Radiol. 1965 Sep;38:685–690. doi: 10.1259/0007-1285-38-453-685. [DOI] [PubMed] [Google Scholar]
  15. COHEN N., MENDELOW H. CONCURRENT "ACTIVE JUVENILE CIRRHOSIS" AND "PRIMARY PULMONARY HYPERTENSION". Am J Med. 1965 Jul;39:127–133. doi: 10.1016/0002-9343(65)90252-4. [DOI] [PubMed] [Google Scholar]
  16. COWLING D. C., MACKAY I. R., TAFT L. I. Lupoid hepatitis. Lancet. 1956 Dec 29;271(6957):1323–1326. doi: 10.1016/s0140-6736(56)91483-0. [DOI] [PubMed] [Google Scholar]
  17. Cook G. C., Mulligan R., Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med. 1971 Apr;40(158):159–185. doi: 10.1093/oxfordjournals.qjmed.a067264. [DOI] [PubMed] [Google Scholar]
  18. Cook G. C., Velasco M., Sherlock S. Effect of corticosteroid therapy on bromsulphthalein excretion in active chronic hepatitis. Gut. 1968 Jun;9(3):270–283. doi: 10.1136/gut.9.3.270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Cooksley W. G., Powell L. W. Drug metabolism and interaction with particular reference to the liver. Drugs. 1971;2(3):177–189. doi: 10.2165/00003495-197102030-00001. [DOI] [PubMed] [Google Scholar]
  20. Cooksley W. G., Powell L. W., Kerr J. F., Bhathal P. S. Cholestasis in active chronic hepatitis. Am J Dig Dis. 1972 Jun;17(6):495–504. doi: 10.1007/BF02231204. [DOI] [PubMed] [Google Scholar]
  21. De Groote J., Desmet V. J., Gedigk P., Korb G., Popper H., Poulsen H., Scheuer P. J., Schmid M., Thaler H., Uehlinger E. A classification of chronic hepatitis. Lancet. 1968 Sep 14;2(7568):626–628. doi: 10.1016/s0140-6736(68)90710-1. [DOI] [PubMed] [Google Scholar]
  22. Doniach D., Roitt I. M., Walker J. G., Sherlock S. Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol. 1966 Jul;1(3):237–262. [PMC free article] [PubMed] [Google Scholar]
  23. Doniach D., Walker J. G. A unified concept of autoimmune hepatitis. Lancet. 1969 Apr 19;1(7599):813–815. doi: 10.1016/s0140-6736(69)92072-8. [DOI] [PubMed] [Google Scholar]
  24. Dudley F. J., Fox R. A., Sherlock S. Cellular immunity and hepatitis-associated, Australia antigen liver disease. Lancet. 1972 Apr 1;1(7753):723–726. doi: 10.1016/s0140-6736(72)90234-6. [DOI] [PubMed] [Google Scholar]
  25. Dudley F. J., Fox R. A., Sherlock S. Relationship of hepatitis-associated antigen (H.A.A.) to acute and chronic liver injury. Lancet. 1971 Jul 3;2(7714):1–3. doi: 10.1016/s0140-6736(71)90001-8. [DOI] [PubMed] [Google Scholar]
  26. Dudley F. J., Giustino V., Sherlock S. Cell-mediated immunity in patients positive for hepatitis-associated antigen. Br Med J. 1972 Dec 30;4(5843):754–756. doi: 10.1136/bmj.4.5843.754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Dudley F. J., O'Shea M. J., Ajdukiewicz A., Sherlock S. Serum autoantibodies and immunoglobulins in hepatitis-associated antigen (HAA)-positive and -negative liver disease. Gut. 1973 May;14(5):360–364. doi: 10.1136/gut.14.5.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Dudley F. J., O'Shea M. J., Sherlock S. Serum autoantibodies in hepatitis associated antigen (HAA) positive patients. A possible index of cell-mediated immunity to the associated-infective agent. Clin Exp Immunol. 1973 Mar;13(3):367–372. [PMC free article] [PubMed] [Google Scholar]
  29. Dudley F. J., Scheuer P. J., Sherlock S. Natural history of hepatitis-associated antigen-positive chronic liver disease. Lancet. 1972 Dec 30;2(7792):1388–1393. doi: 10.1016/s0140-6736(72)92963-7. [DOI] [PubMed] [Google Scholar]
  30. Elkington S. G., Schreiber W. M., Conn H. O. Hepatic injury caused by L-alpha-methyldopa. Circulation. 1969 Oct;40(4):589–595. doi: 10.1161/01.cir.40.4.589. [DOI] [PubMed] [Google Scholar]
  31. Elling P., Ranlov P., Bildsoe P. A genetic approach to the pathogenesis of hepatic cirrhosis. A clinical and serological study. Acta Med Scand. 1966 May;179(5):527–533. doi: 10.1111/j.0954-6820.1966.tb07969.x. [DOI] [PubMed] [Google Scholar]
  32. FRANKLIN M., BEAN W. B., PAUL W. D., ROUTH J. I., HUERGA J. de la, POPPER H. Electrophoretic studies in liver disease. II. Gamma globulin in chronic liver disease. J Clin Invest. 1951 Jul;30(7):729–737. doi: 10.1172/JCI102486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Feizi T. Immunoglobulins in chronic liver disease. Gut. 1968 Apr;9(2):193–198. doi: 10.1136/gut.9.2.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Feizi T., Naccarato R., Sherlock S., Doniach D. Mitochondrial and other tissue antibodies in relatives of patients with primary biliary cirrhosis. Clin Exp Immunol. 1972 Apr;10(4):609–622. [PMC free article] [PubMed] [Google Scholar]
  35. Fox R. A., Niazi S. P., Sherlock S. Hepatitis-associated antigen in chronic liver disease. Lancet. 1969 Sep 20;2(7621):609–612. doi: 10.1016/s0140-6736(69)90324-9. [DOI] [PubMed] [Google Scholar]
  36. Fox R. A., Niazi S. P., Sherlock S. Hepatitis-associated antigen in chronic liver disease. Lancet. 1969 Sep 20;2(7621):609–612. doi: 10.1016/s0140-6736(69)90324-9. [DOI] [PubMed] [Google Scholar]
  37. GAJDUSEK D. C. An autoimmune reaction against human tissue antigens in certain acute and chronic diseases. I. Serological investigations. AMA Arch Intern Med. 1958 Jan;101(1):9–29. doi: 10.1001/archinte.1958.00260130023003. [DOI] [PubMed] [Google Scholar]
  38. Galbraith R. M., Smith M., Mackenzie R. M., Tee D. E., Doniach D., Williams R. High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis. N Engl J Med. 1974 Jan 10;290(2):63–69. doi: 10.1056/NEJM197401102900201. [DOI] [PubMed] [Google Scholar]
  39. Golding P. L., Bown R., Mason A. M., Taylor E. "Sicca complex" in liver disease. Br Med J. 1970 Nov 7;4(5731):340–342. doi: 10.1136/bmj.4.5731.340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Golding P. L., Mason A. S. Renal tubular acidosis and autoimmune liver disease. Gut. 1971 Feb;12(2):153–157. doi: 10.1136/gut.12.2.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Golding P. L., Smith M., Williams R. Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis. Am J Med. 1973 Dec;55(6):772–782. doi: 10.1016/0002-9343(73)90258-1. [DOI] [PubMed] [Google Scholar]
  42. Goldstein G. B., Lam K. C., Mistilis S. P. Drug-induced active chronic hepatitis. Am J Dig Dis. 1973 Mar;18(3):177–184. doi: 10.1007/BF01071970. [DOI] [PubMed] [Google Scholar]
  43. HOLDSWORTH C. D., HALL E. W., DAWSON A. M., SHERLOCK S. ULCERATIVE COLITIS IN CHRONIC LIVER DISEASE. Q J Med. 1965 Apr;34:211–227. [PubMed] [Google Scholar]
  44. Hadziyannis S., Gerber M. A., Vissoulis C., Popper H. Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers. Arch Pathol. 1973 Nov;96(5):327–330. [PubMed] [Google Scholar]
  45. Hourigan K., Sherlock S., George P., Mindel S. Elective end-to-side portacaval shunt: results in 64 cases. Br Med J. 1971 Nov 20;4(5785):473–477. doi: 10.1136/bmj.4.5785.473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Johnson G. D., Holborow E. J., Glynn L. E. Antibody to smooth muscle in patients with liver disease. Lancet. 1965 Oct 30;2(7418):878–879. doi: 10.1016/s0140-6736(65)92505-5. [DOI] [PubMed] [Google Scholar]
  47. Joske R. A., Laurence B. H. Familial cirrhosis with autoimmune features and raised immunoglobulin levels. Gastroenterology. 1970 Oct;59(4):546–552. [PubMed] [Google Scholar]
  48. Le Bouvier G. L. Editorial: Subtypes of hepatitis B antigen: clinical relevance? Ann Intern Med. 1973 Dec;79(6):894–896. doi: 10.7326/0003-4819-79-6-894. [DOI] [PubMed] [Google Scholar]
  49. MACLACHLAN M. J., RODNAN G. P., COOPER W. M., FENNELL R. H., Jr CHRONIC ACTIVE ("LUPOID") HEPATITIS; A CLINICAL, SEROLOGICAL, AND PATHOLOGICAL STUDY OF 20 PATIENTS. Ann Intern Med. 1965 Mar;62:425–462. doi: 10.7326/0003-4819-62-3-425. [DOI] [PubMed] [Google Scholar]
  50. MUSCHEL L. H., SIMONTON L. A., WELLS P. A., FIFE E. H., Jr Occurrence of complement-fixing antibodies reactive with normal tissue constituents in normal and disease states. J Clin Invest. 1961 Mar;40:517–524. doi: 10.1172/JCI104279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. MUSCHEL L. H., SIMONTON L. A., WELLS P. A., FIFE E. H., Jr Occurrence of complement-fixing antibodies reactive with normal tissue constituents in normal and disease states. J Clin Invest. 1961 Mar;40:517–524. doi: 10.1172/JCI104279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Mackay I. R. Chronic hepatitis: effect of prolonged suppressive treatment and comparison of azathioprine with prednisolone. Q J Med. 1968 Jul;37(147):379–392. [PubMed] [Google Scholar]
  53. Mackay I. R., Morris P. J. Association of autoimmune active chronic hepatitis with HL-A1,8. Lancet. 1972 Oct 14;2(7781):793–795. doi: 10.1016/s0140-6736(72)92149-6. [DOI] [PubMed] [Google Scholar]
  54. Maddrey W. C., Boitnott J. K. Isoniazid hepatitis. Ann Intern Med. 1973 Jul;79(1):1–12. doi: 10.7326/0003-4819-79-1-1. [DOI] [PubMed] [Google Scholar]
  55. Mathews J. D., Mackay I. R. Australia antigen in chronic hepatitis in Australia. Br Med J. 1970 Jan 31;1(5691):259–261. doi: 10.1136/bmj.1.5691.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Mistilis S. P., Blackburn C. R. Active chronic hepatitis. Am J Med. 1970 Apr;48(4):484–495. doi: 10.1016/0002-9343(70)90049-5. [DOI] [PubMed] [Google Scholar]
  57. Mistilis S. P., Blackburn C. R. The treatment of active chronic hepatitis with 6-mercaptopurine and azathioprine. Australas Ann Med. 1967 Nov;16(4):305–311. doi: 10.1111/imj.1967.16.4.305. [DOI] [PubMed] [Google Scholar]
  58. Morris R. C., Jr Renal tubular acidosis. Mechanisms, classification and implications. N Engl J Med. 1969 Dec 18;281(25):1405–1413. doi: 10.1056/NEJM196912182812508. [DOI] [PubMed] [Google Scholar]
  59. Murray-Lyon I. M., Stern R. B., Williams R. Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet. 1973 Apr 7;1(7806):735–737. doi: 10.1016/s0140-6736(73)92125-9. [DOI] [PubMed] [Google Scholar]
  60. PAGE A. R., GOOD R. A. Plasma-cell hepatitis, with special attention to steroid therapy. AMA J Dis Child. 1960 Mar;99:288–314. doi: 10.1001/archpedi.1960.02070030290006. [DOI] [PubMed] [Google Scholar]
  61. PASNICK L. J., BEALL G. N., VANARSDEL P. P., Jr Complement fixing reactions with liver tissue in human disease. Am J Med. 1962 Nov;33:774–782. doi: 10.1016/0002-9343(62)90254-1. [DOI] [PubMed] [Google Scholar]
  62. Page A. R., Good R. A., Pollara B. Long-term results of therapy in patients with chronic liver disease associated with hypergammaglobulinemia. Am J Med. 1969 Nov;47(5):765–774. doi: 10.1016/0002-9343(69)90169-7. [DOI] [PubMed] [Google Scholar]
  63. Palmer P. E., Wolfe H. J., Gherardi G. J. Hepatic changes in adult alpha-1-antitrypsin deficiency. Gastroenterology. 1973 Aug;65(2):284–293. [PubMed] [Google Scholar]
  64. Palmer P. E., Wolfe H. J., Gherardi G. J. Hepatic changes in adult alpha-1-antitrypsin deficiency. Gastroenterology. 1973 Aug;65(2):284–293. [PubMed] [Google Scholar]
  65. Powell L. W., Axelsen E. Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding. Gut. 1972 Sep;13(9):690–696. doi: 10.1136/gut.13.9.690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. READ A. E., SHERLOCK S., HARRISON C. V. ACTIVE 'JUVENILE' CIRRHOSIS CONSIDERED AS PART OF A SYSTEMIC DISEASE AND THE EFFECT OF CORTICOSTEROID THERAPY. Gut. 1963 Dec;4:378–393. doi: 10.1136/gut.4.4.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Rehman O. U., Keith T. A., Gall E. A. Methyldopa-induced submassive hepatic necrosis. JAMA. 1973 Jun 4;224(10):1390–1392. [PubMed] [Google Scholar]
  68. Reynolds T. B., Peters R. L., Yamada S. Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin. N Engl J Med. 1971 Oct 7;285(15):813–820. doi: 10.1056/NEJM197110072851501. [DOI] [PubMed] [Google Scholar]
  69. Rössler R., Havemann K., Dölle W. Unterschiedliche Reaktion von Lymphocyten auf Phythämagglutinin (PHA) bei Lebererkrankungen. Klin Wochenschr. 1969 Aug 1;47(15):803–806. doi: 10.1007/BF01882306. [DOI] [PubMed] [Google Scholar]
  70. SILVA H., HALL E. W., HILL K. R., SHALDON S., SHERLOCK S. RENAL INVOLVEMENT IN ACTIVE "JUVENILE" CIRRHOSIS. J Clin Pathol. 1965 Mar;18:157–163. doi: 10.1136/jcp.18.2.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Sarkany I. Juvenile cirrhosis and allergic capillaritis of the skin. A hepato-cutaneous syndrome. Lancet. 1966 Sep 24;2(7465):666–668. doi: 10.1016/s0140-6736(66)92830-3. [DOI] [PubMed] [Google Scholar]
  72. Schweitzer I. L., Mosley J. W., Ashcaval M., Edwards V. M., Overby L. B. Factors influencing neonatal infection by hepatitis B virus. Gastroenterology. 1973 Aug;65(2):277–283. [PubMed] [Google Scholar]
  73. Sherlock S., Fox R. A., Niazi S. P., Scheuer P. J. Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. Lancet. 1970 Jun 13;1(7659):1243–1247. doi: 10.1016/s0140-6736(70)91737-x. [DOI] [PubMed] [Google Scholar]
  74. Soloway R. D., Summerskill W. H., Baggenstoss A. H., Geall M. G., Gitnićk G. L., Elveback I. R., Schoenfield L. J. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology. 1972 Nov;63(5):820–833. [PubMed] [Google Scholar]
  75. Stanley N. N., Woodgate D. J. The circulation, the lung, and finger clubbing in hepatic cirrhosis. Br Heart J. 1971 Jul;33(4):469–472. doi: 10.1136/hrt.33.4.469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Sternlieb I., Scheinberg I. H. Chronic hepatitis as a first manifestation of Wilson's disease. Ann Intern Med. 1972 Jan;76(1):59–64. doi: 10.7326/0003-4819-76-1-59. [DOI] [PubMed] [Google Scholar]
  77. Summerskill W. H. Chronic active liver disease reexamined: prognosis hopeful. Gastroenterology. 1974 Mar;66(3):450–464. [PubMed] [Google Scholar]
  78. Tobias H., Safran A. P., Schaffner F. Lymphocyte stimulation and chronic liver disease. Lancet. 1967 Jan 28;1(7483):193–195. doi: 10.1016/s0140-6736(67)91830-2. [DOI] [PubMed] [Google Scholar]
  79. Toh B. H., Roberts-Thomson I. C., Mathews J. D., Whittingham S., Mackay I. R. Depression of cell-mediated immunity in old age and the immunopathic diseases, lupus erythematosus, chronic hepatitis and rheumatoid arthritis. Clin Exp Immunol. 1973 Jun;14(2):193–202. [PMC free article] [PubMed] [Google Scholar]
  80. Turner-Warwick M. Fibrosing alveolitis and chronic liver disease. Q J Med. 1968 Jan;37(145):133–149. [PubMed] [Google Scholar]
  81. Vido I., Selmair H., Wildhirt E., Ortmans H. Zur Prognose der chronischen Hepatitis. 1. Formen und Entwicklungsstadien. Dtsch Med Wochenschr. 1969 Oct 24;94(43):2215–passim. doi: 10.1055/s-0028-1110419. [DOI] [PubMed] [Google Scholar]
  82. WALKER J. G., DONIACH D., ROITT I. M., SHERLOCK S. SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS. Lancet. 1965 Apr 17;1(7390):827–831. doi: 10.1016/s0140-6736(65)91372-3. [DOI] [PubMed] [Google Scholar]
  83. WILLOCX R. G., ISSELBACHER K. J. Chronic liver disease in young people. Clinical features and course in thirty-three patients. Am J Med. 1961 Feb;30:185–195. doi: 10.1016/0002-9343(61)90090-0. [DOI] [PubMed] [Google Scholar]
  84. Walker J. G., Doniach D., Doniach I. Mitochondrial antibodies and subclinical liver disease. Q J Med. 1970 Jan;39(153):31–48. [PubMed] [Google Scholar]
  85. Whelan G., Sherlock S. Immunosuppressive activity in patients with active chronic hepatitis and primary biliary cirrhosis treated with azathioprine. Gut. 1972 Nov;13(11):907–914. doi: 10.1136/gut.13.11.907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Whittingham S., Mackay I. R., Irwin J. Autoimmune hepatitis. Immunofluorescence reactions with cytoplasm of smooth muscle and renal glomerular cells. Lancet. 1966 Jun 18;1(7451):1333–1335. doi: 10.1016/s0140-6736(66)92131-3. [DOI] [PubMed] [Google Scholar]
  87. Wright R., McCollum R. W., Klatskin G. Australia antigen in acute and chronic liver disease. Lancet. 1969 Jul 19;2(7612):117–121. doi: 10.1016/s0140-6736(69)92437-4. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES